Fapy·dG Oligonucleotide Synthesis via Reverse Phosphoramidite Strategy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The difficulty in synthesizing oligonucleotides containing N6-(2-Deoxy-α,β-D-erythropentofuranosyl)-2,6-diamino-4-hydroxy-5-formamidopyrimidine (Fapy·dG) hinders understanding of its impact on DNA structure and function, as current methods are inefficient and complex, limiting research on this important DNA lesion.
Innovation Solution
A method for synthesizing oligonucleotides involving a nucleoside phosphoramidite with a dimethoxytrityl protecting group and a phosphoramidite moiety, using a solid phase support with Fapy·dG attached via a succinate linkage, and employing activators like 4,5-dicyanoimidazole and oxidizing agents like tert-butyl hydroperoxide to form a phosphate triester, followed by detritylation, demethylation, and purification using HPLC or gel electrophoresis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional synthesis methods are used for oligonucleotides containing Fapy·dG, then the synthesis process can be performed, but the process is inefficient and complex with low yield
Solution Approach 1:
The synthesis process is divided into modular phosphoramidite building blocks (Fapy·dG phosphoramidite, protected nucleoside phosphoramidites) that can be independently prepared and then assembled through standardized coupling reactions on solid phase support, transforming a complex one-step synthesis into manageable sequential steps
Solution Approach 2:
The Fapy·dG moiety is pre-synthesized and converted to its phosphoramidite derivative before being incorporated into the oligonucleotide chain, allowing the complex structural features to be prepared in advance under optimized conditions rather than attempting to form them during chain assembly
2Quantity of substance
If conventional synthesis methods are used for oligonucleotides containing Fapy·dG, then the synthesis can proceed, but the yield is low
Solution Approach 1:
The method employs disposable solid phase support beads that carry the growing oligonucleotide chain, allowing each synthesis cycle to proceed with high efficiency while the support is discarded after a single use, eliminating the need for complex purification and regeneration steps that would reduce overall yield
Solution Approach 2:
The synthesis conditions are optimized by adjusting parameters such as activator concentration (e.g., 0.25 M 4,5-dicyanoimidazole in acetonitrile), coupling time (900 seconds), and oxidizing agent (tert-butyl hydroperoxide) to maximize coupling efficiency and minimize degradation of the sensitive Fapy·dG moiety
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the robust synthesis of oligonucleotides containing Fapy·dG, facilitating biochemical and structural studies, and is compatible with synthesizing other biologically significant DNA lesions, improving upon previous methods by increasing yield and simplifying the process.
Implementation Method 1
contacting the nucleoside phosphoramidite of (a) with one or more nucleoside residues attached to a solid phase support to form a solid support-bound product
Implementation Method 2
contacting the solid support-bound product with an oxidizing agent to form an oxidized solid support-bound product
Implementation Method 3
contacting the nucleoside phosphoramidite having a dimethoxytrityl protecting group at the 3'-hydroxyl position with trichloroacetic acid (TCA) or dichloroacetic acid (DCA)
Implementation Method 4
a single Fapy·dG moiety on a reverse 3'-thymidine support comprising a succinate linkage between the 5'-hydroxyl group and a long chain alkylamine linker to the solid phase support
Data Source
AI summary
A strategy using reverse phosphoramidites for synthesizing oligonucleotides containing Fapy·dG is disclosed.